Commentary on "Alpha-synuclein and mitochondria: A tangled skein"

Experimental Neurology

Volumn 186, Issue 2, 2004, Pages 109-111

  Beal, M Flint ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; ALPHA SYNUCLEIN; NEURON SPECIFIC ENOLASE;

CELL INCLUSION; CELL ULTRASTRUCTURE; CORPUS STRIATUM; GENE OVEREXPRESSION; HIPPOCAMPUS; HUMAN; LEWY BODY; MITOCHONDRIAL DNA DISORDER; NEOCORTEX; NOTE; PARKINSON DISEASE; PERIMETRY; PRIORITY JOURNAL; SPECIES COMPARISON; SUBSTANTIA NIGRA; TRANSGENIC MOUSE; TRANSMISSION ELECTRON MICROSCOPY; WILD TYPE;

1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE; ALPHA-SYNUCLEIN; ANIMALS; BRAIN; DOPAMINE AGENTS; MICE; MICE, TRANSGENIC; MITOCHONDRIA; NERVE TISSUE PROTEINS; PARKINSON DISEASE; SYNUCLEINS;

EID: 1542513232     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.expneurol.2003.12.002     Document Type: Note

References (20)

1. Auluck P.K., Chan H.Y., Trojanowski J.Q., Lee V.M., Bonini N.M. Chaperone suppression of alpha-synuclein toxicity in a Drosophila model for Parkinson's disease. Science. 295:2002;865-868.
2. Betarbet R., Sherer T.B., MacKenzie G., Garcia-Osuna M., Panov A.V., Greenamyre J.T. Chronic systemic pesticide exposure reproduces features of Parkinson's disease. Nat. Neurosci. 3:2000;1301-1306.
3. Dauer W., Kholodilov N., Vila M., Trillat A.C., Goodchild R., Larsen K.E., Staal R., Tieu K., Schmitz Y., Yuan C.A., Rocha M., Jackson-Lewis V., Hersch S., Sulzer D., Przedborski S., Burke R., Hen R. Resistance of alpha-synuclein null mice to the parkinsonian neurotoxin MPTP. Proc. Natl. Acad. Sci. U. S. A. 99:2002;14524-14529.
4. Feany M.B., Bender W.W. A Drosophila model of Parkinson's disease. Nature. 404:2000;394-398.
5. Gai W.P., Yuan H.X., Li X.Q., Power J.T., Blumbergs P.C., Jensen P.H. In situ and in vitro study of colocalization and segregation of alpha-synuclein, ubiquitin, and lipids in Lewy bodies. Exp. Neurol. 166:2000;324-333.
6. Gohil K., Schock B.C., Chakraborty A.A., Terasawa Y., Raber J., Farese R.V. Jr., Packer L., Cross C.E., Traber M.G. Gene expression profile of oxidant stress and neurodegeneration in transgenic mice deficient in α-tocopherol transfer protein. Free Radic. Biol. Med. 35:2003;1343-1354.
7. Gosavi N., Lee H.J., Lee J.S., Patel S., Lee S.J. Golgi fragmentation occurs in the cells with prefibrillar alpha-synuclein aggregates and precedes the formation of fibrillar inclusion. J. Biol. Chem. 277:2002;48984-48992.
8. Greene J.C., Whitworth A.J., Kuo I., Andrews L.A., Feany M.B., Pallanck L.J. Mitochondrial pathology and apoptotic muscle degeneration in Drosophila parkin mutants. Proc. Natl. Acad. Sci. U. S. A. 100:2003;4078-4083.
9. Hsu L.J., Sagara Y., Arroyo A., Rockenstein E., Sisk A., Mallory M., Wong J., Takenouchi T., Hashimoto M., Masliah E. α-Synuclein promotes mitochondrial deficit and oxidative stress. Am. J. Pathol. 157:2000;401-410.
10. Hyun D.-H., Lee M.H., Hattori N., Kubo S-I., Mizuno Y., Halliwell B., Jenner P. Effect of wild-type or mutant parkin on oxidative damage, nitric oxide, antioxidant defenses, and the proteasome. J. Biol. Chem. 277:2002;28572-28577.
11. Kowall N.W., Hantraye P., Brouillet E., Beal M.F., McKee A.C., Ferrante R.J. MPTP induces alpha-synuclein aggregation in the substantia nigra of baboons. NeuroReport. 11:2000;211-213.
12. Lee H.-J., Shin S.-Y., Choi C., Han Lee Y., Lee S.-J. Formation and removal of α-synuclein aggregates in cells exposed to mitochondrial inhibitors. J. Biol. Chem. 277:2002;5411-5417.
13. Orth M., Tabrizi S.J., Schapira A.H.V., Cooper J.M. α-Synuclein expression in HEK293 cells enhances the mitochondrial sensitivity to rotenone. Neurosci. Lett. 351:2003;29-32.
14. Rathke-Hartlieb S., Kahle P.J., Neumann M., Ozmen L., Haid S., Okochi M., Haass C., Schulz J.B. Sensitivity to MPTP is not increased in Parkinson's disease-associated mutant alpha-synuclein transgenic mice. J. Neurochem. 77:2001;1181-1184.
15. Sherer T.B., Betarbet R., Stout A.K., Lund S., Baptista M., Panov A.V., Cookson M.R., Greenamyre J.T. An in vitro model of Parkinson's disease: linking mitochondrial impairment to altered α-synuclein metabolism and oxidative damage. J. Neurosci. 22:2002;7006-7015.
16. Sherer T.B., Betarbet R., Testa C.M., Seo B.B., Richardson J.R., Kim J.H., Miller G.W., Yagi T., Matsuno-Yagi A., Greenamyre J.T. Mechanism of toxicity in rotenone models of Parkinson's disease. J. Neurosci. 23:2003;10756-10764.
17. Singleton A.B., Farrer M., Johnson J., Singleton A., Hague S., Kachergus J., Hulihan M., Peuralinna T., Dutra A., Nussbaum R., Lincoln S., Crawley A., Hanson M., Maraganore D., Adler C., Cookson M.R., Muenter M., Baptisa M., Miller D., Blancato J., Hardy J., Gwinn-Hardy K. α-Synuclein locus triplication causes Parkinson's disease. Science. 302:2003;841.
18. Song D.D., Shults C.W., Sisk A., Rockenstein E., Masliah E. Enhanced substantia nigra mitochondrial pathhology in human α-synuclein transgenic mice after treatment with MPTP. Exp. Neurol. 186:2004;158-172.
19. Tanaka Y., Engelender S., Igarashi S., Rao R.K., Wanner T., Tanzi R.E., Sawa A., Dawson V.L., Dawson T.M., Ross C.A. Inducible expression of mutant α-synuclein decreases proteasome activity and increases sensitivity to mitochondria-dependent apoptosis. Hum. Mol. Genet. 10:2001;919-926.
20. Vila M., Vukosavic S., Jackson-lewis V., Neystat M., Jakowec M., Przedborski S. Alpha-synuclein up-regulation in substantia nigra dopaminergic neurons following administration of the parkinsonian toxin MPTP. J. Neurochem. 74:2000;721-729.